Cathepsins and cystatin C in atherosclerosis and obesity

被引:98
作者
Lafarge, Jean-Charles [2 ,3 ]
Naour, Nadia [2 ,3 ]
Clement, Karine [2 ,3 ,4 ,5 ]
Guerre-Millo, Michele [1 ,2 ,3 ]
机构
[1] Ctr Rech Cordeliers, INSERM, U872, F-75006 Paris, France
[2] Univ Paris 06, Ctr Rech Cordeliers, UMR S 872, F-75006 Paris, France
[3] Univ Paris 05, UMR S 872, F-75006 Paris, France
[4] Hop La Pitie Salpetriere, AP HP, Dept Nutr & Endocrinol, F-75013 Paris, France
[5] Ctr Res Human Nutr Ile France, F-75013 Paris, France
关键词
Cathepsins; Cystatin C; Atherosclerosis; Obesity; OMENTAL ADIPOSE-TISSUE; CORONARY-HEART-DISEASE; CYSTEINE PROTEASES; REDUCES ATHEROSCLEROSIS; MACROPHAGE INFILTRATION; CARDIOVASCULAR EVENTS; SERUM CREATININE; DEFICIENCY; PROGRESSION; EXPRESSION;
D O I
10.1016/j.biochi.2010.04.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Given the increasing prevalence of human obesity worldwide, there is an urgent need for a better understanding of the molecular mechanisms linking obesity to metabolic and cardiovascular diseases. Our knowledge is nevertheless limited regarding molecules linking adipose tissue to downstream complications. The importance of cathepsins was brought to light in this context. Through a large scale transcriptomic analysis, our group recently identified the gene encoding cathepsin S as one of the most deregulated gene in the adipose tissue of obese subjects and positively correlated with body mass index. Other members of the cathepsin family are expressed in the adipose tissue, including cathepsin K and cathepsin L Given their implication in atherogenesis, these proteases could participate into the well established deleterious relationship between enlarged adipose tissue and increased cardiovascular risk. Here, we review the clinical and experimental evidence relevant to the role of cathepsins K, L and S and their most abundant endogenous inhibitor, cystatin C, in atherosclerosis and in obesity. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1580 / 1586
页数:7
相关论文
共 60 条
[41]   Destabilizing role of cathepsin S in murine atherosclerotic plaques [J].
Rodgers, KJ ;
Watkins, DJ ;
Miller, AL ;
Chan, PY ;
Karanam, S ;
Brissette, WH ;
Long, CJ ;
Jackson, CL .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (04) :851-856
[42]   Role of cathepsin K in structural changes in brachiocephalic artery during progression of atherosclerosis in apoE-deficient mice [J].
Samokhin, Andriy O. ;
Wong, Andre ;
Saftig, Paul ;
Broemme, Dieter .
ATHEROSCLEROSIS, 2008, 200 (01) :58-68
[43]   Cystatin C deficiency in human atherosclerosis and aortic aneurysms [J].
Shi, GP ;
Sukhova, GK ;
Grubb, A ;
Ducharme, A ;
Rhode, LH ;
Lee, RT ;
Ridker, PM ;
Libby, P ;
Chapman, HA .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (09) :1191-1197
[44]   Cystatin C and the risk of death and cardiovascular events among elderly persons [J].
Shlipak, MG ;
Sarnak, MJ ;
Katz, R ;
Fried, LF ;
Seliger, SL ;
Newman, AB ;
Siscovick, DS ;
Stehman-Breen, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (20) :2049-2060
[45]   Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice [J].
Sukhova, GK ;
Wang, B ;
Libby, P ;
Pan, JH ;
Zhang, Y ;
Grubb, A ;
Fang, K ;
Chapman, HA ;
Shi, GP .
CIRCULATION RESEARCH, 2005, 96 (03) :368-375
[46]   Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice [J].
Sukhova, GK ;
Zhang, Y ;
Pan, JH ;
Wada, Y ;
Yamamoto, T ;
Naito, M ;
Kodama, T ;
Tsimikas, S ;
Witztum, JL ;
Lu, ML ;
Sakara, Y ;
Chin, MT ;
Libby, P ;
Shi, GP .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (06) :897-906
[47]   Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells [J].
Sukhova, GK ;
Shi, GP ;
Simon, DI ;
Chapman, HA ;
Libby, P .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (03) :576-583
[48]   Weight loss reduces adipose tissue cathepsin S and its circulating levels in morbidly obese women [J].
Taleb, S ;
Cancello, R ;
Poitou, C ;
Rouault, C ;
Sellam, P ;
Levy, P ;
Bouillot, JL ;
Coussieu, C ;
Basdevant, A ;
Guerre-Millo, M ;
Lacasa, D ;
Clement, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (03) :1042-1047
[49]   Cathepsin S, a novel biomarker of adiposity: relevance to atherogenesis [J].
Taleb, S ;
Lacasa, D ;
Bastard, JP ;
Poitou, C ;
Cancello, R ;
Pelloux, V ;
Viguerie, N ;
Benis, A ;
Zucker, JD ;
Bouillot, JL ;
Coussieu, C ;
Basdevant, A ;
Langin, D ;
Clement, K .
FASEB JOURNAL, 2005, 19 (08) :1540-+
[50]   Cathepsin S promotes human preadipocyte differentiation:: Possible involvement of fibronectin degradation [J].
Taleb, Soraya ;
Cancello, Raffaella ;
Clement, Karine ;
Lacasa, Daniele .
ENDOCRINOLOGY, 2006, 147 (10) :4950-4959